Clinical Trial Update: The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: a Randomized Control Study [Phase 2]

View source ↗

Summary

Phase 2 randomized trial to evaluate the safety and efficacy of sirolimus in primary antiphospholipid syndrome; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Primary Antiphospholipid Syndrome | Phase 2 | Status: NOT_YET_RECRUITING